These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11086865)

  • 1. Regulatory issues in the era of highly active antiretroviral therapy.
    Murray JS
    AIDS; 2000; 14 Suppl 3():S219-25. PubMed ID: 11086865
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
    Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
    Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiretroviral drugs in development.
    Murphy RL
    AIDS; 2000; 14 Suppl 3():S227-34. PubMed ID: 11086866
    [No Abstract]   [Full Text] [Related]  

  • 4. [Approval of a new nucleoside. Component of complete once daily regimen].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373067
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance and other factors involved in therapy failure.
    Mallol S
    Antivir Ther; 2001; 6 Suppl 2():21-7. PubMed ID: 11678475
    [No Abstract]   [Full Text] [Related]  

  • 6. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioequivalent formulation for the fixed-dose regimen of Truvada and TMC278 finalized.
    AIDS Patient Care STDS; 2010 Jun; 24(6):395-6. PubMed ID: 20575158
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial antiretroviral drugs.
    Rojo P; Gonzalez-Tome MI; Ramos JT
    Pediatr Infect Dis J; 2007 Dec; 26(12):1167; author reply 1167. PubMed ID: 18043466
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 11. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
    Murphy RL
    AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in antiretroviral treatment.
    Sadovsky R
    Am Fam Physician; 1999 Dec; 60(9):2663, 2666. PubMed ID: 10605997
    [No Abstract]   [Full Text] [Related]  

  • 13. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy?
    Chang SY; Lin SW; Hung CC
    Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849
    [No Abstract]   [Full Text] [Related]  

  • 14. [New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():66-8. PubMed ID: 16385881
    [No Abstract]   [Full Text] [Related]  

  • 15. Design issues in initial HIV-treatment trials: focus on ACTG A5095.
    Ribaudo HJ; Kuritzkes DR; Schackman BR; Acosta EP; Shikuma CM; Gulick RM
    Antivir Ther; 2006; 11(6):751-60. PubMed ID: 17310819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and durability of non-nucleoside reverse transcriptase inhibitor-based therapy in HIV clinical practice.
    Kan VL
    AIDS; 2007 Apr; 21(7):880-2. PubMed ID: 17415048
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for the use of antiretroviral agents in HIV infections in Taiwan.
    J Microbiol Immunol Infect; 2001 Sep; 34(3):224-6. PubMed ID: 11605817
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.